Salute e Benessere

Sequana Medical announces results of Annual and Extraordinary General Meetings…

PRESS RELEASE REGULATED INFORMATION23 May 2024, 06:00 pm CESTGhent, Belgium – 23 May 2024– Sequana Medical NV (Euronext Brussels: SEQUA)(the " Company " or " SequanaMedical "), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, today announces that all proposed resolutions submitted to the Annual and Extraordinary General Meetings of Shareholders were approved at the meetings held today at 09:00 am CEST.The items on the agendas of...
Nasdaq GlobeNewswire
23/05/2024

Pancreatic Cancer Battle Intensifies: Biotech Innovations Aim to Boost Survival…

Pelareorep, an innovative immunotherapeutic agent developed by Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC), is making significant strides in the treatment of various cancers, particularly breast and pancreatic cancer. After securing Fast Track Designation from the FDA for its use in pancreatic cancer in late 2022 due to promising clinical results, the company has initiated a preliminary collaboration with the Global Coalition for Adaptive Research (GCAR). This collaboration focuses on…
PR Newswire
23/05/2024

Healthcare Artificial Intelligence Market to Be Worth $176.4 Billion by 2031 -…

Healthcare is one of the most critical sectors in the broader landscape of big data because of its fundamental role in a productive, thriving society. AI in healthcare is a term used to describe the application of machine learning (ML) algorithms and other cognitive technologies in medical settings. AI helps to assist doctors, nurses, and other healthcare workers in their daily work. AI in healthcare enhances preventive care and quality of life, produces more accurate diagnoses and treatment…
PR Newswire
23/05/2024

Foot Orthotic Insole Market Size is Expected to Reach US$ 9.44 Billion by 2034 |…

More people across the world are experiencing several orthopedic issues such as diabetic foot ulcers, sports injuries, and injuries due to accidents. This factor is contributing to the increasing adoption of foot orthotic insoles. Manufacturers are bolstering their market stance by producing customized insoles as per varied consumer needs. More people across the world are experiencing several orthopedic issues such as diabetic foot ulcers, sports injuries, and injuries due to accidents...
PR Newswire
23/05/2024

Continuous Bioprocessing Market to Be Worth $1.32 Billion by 2031 - Exclusive…

Continuous bioprocessing has become a major trend in biopharmaceutical manufacturing due to its agility, flexibility, efficiency, and robustness. It reduces the number of steps and holds, requires smaller facilities with limited equipment, and improves product quality, enabling real-time release. Advantages such as cost efficiency and improved product quality are expected to drive the adoption of continuous bioprocessing in the biopharmaceutical industry in the coming years. Continuous…
PR Newswire
23/05/2024

Cannabis Testing Market Worth $4.0 billion | MarketsandMarkets™

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=46932450 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=46932450 Browse in-depth TOC on "Cannabis Testing Market" 439 - Tables 52 - Figures 378 - Pages Cannabis Testing Market Scope: Products segment held the highest estimated share of the cannabis testing market. Based on product & software, the cannabis testing market is...
PR Newswire
23/05/2024

Wheelchair Cushions Market Size to Hit USD 890.4 Mn by 2031

Market Dynamics: Market Dynamics : The wheelchair cushions market is experiencing significant growth owing to rising incidences of road accidents and chronic diseases such as arthritis. According to the World Health Organization (WHO), road traffic injuries cause around 1.35 million deaths annually. Moreover, as per the Arthritis Foundation, over 54 million adults have been diagnosed with arthritis in the U.S., which is a leading cause of disability. Wheelchair cushions provide comfort and...
PR Newswire
23/05/2024

3D Printing Photopolymer Market Worth USD 2,902.4 Million by 2031 - Exclusive…

The use of 3D printing in industries is commonly referred to as additive manufacturing (AM). With the use of software and a 3-dimensional printer, additive manufacturing comprises the layer-by-layer addition of material to construct an item, referring to a three-dimensional file. Significant use of 3D printing technology in pharmaceutical applications and aerospace & defence parts is anticipated to drive the market. The use of 3D printing in industries is commonly referred to as additive...
PR Newswire
23/05/2024

Veterinary API Market to Be Worth $15.84 Billion by 2031 - Exclusive Report by…

Veterinary APIs are a critical component of the animal healthcare industry. It involves the production of essential compounds for the formation of animal pharmaceuticals/veterinary drugs. These APIs are the biologically active components responsible for the therapeutic effects in animals when they receive medical care. Veterinary APIs are a critical component of the animal healthcare industry. It involves the production of essential compounds for the formation of animal...
PR Newswire
23/05/2024

Robotic Surgery Consumables Market Worth USD 12.3 Billion to 2031 - Exclusive…

The global robotic surgery consumables market has witnessed remarkable growth driven by advancements in minimally invasive surgical techniques and the increasing adoption of robotic-assisted surgeries. These consumables encompass various instruments and accessories utilized in robotic surgical procedures, including surgical staplers, scalpels, sutures, and electrosurgical tools. The global robotic surgery consumables market has witnessed remarkable growth driven by advancements in minimally...
PR Newswire
23/05/2024

Infant Milk Formula Market Poised for 13.5% CAGR Surge, Targeting $22.35 Billion…

Since milk is a key nutritional choice for infants, the market for baby milk formula is growing at a remarkable pace. For those moms who are hesitant to breastfeed, milk formula is the only alternative. Milk formula supplies all of the nutrients the infant needs to stay healthy. Since milk is a key nutritional choice for infants, the market for baby milk formula is growing at a remarkable pace. For those moms who are hesitant to breastfeed, milk formula is the only alternative. Milk formula...
PR Newswire
23/05/2024

Precision Diagnostics Market Size to Hit USD 196.45 Bn by 2031: Coherent Market…

Market Dynamics: Market Dynamics : Rising prevalence of chronic and infectious diseases globally is expected to drive growth of the precision diagnostics market during the forecast period. According to WHO, chronic diseases accounted for approximately 60% of the 57 million global deaths in 2008, and chronic disease mortality is projected to rise by 15% globally between 2010 and 2020. In addition, advancements in genomic technologies have enabled development of precision diagnostics tools to...
PR Newswire
23/05/2024

Global Ambulatory Surgical Centers Market is Projected to Boost at a Moderate…

Key Takeaways from the Ambulatory Surgical Centers Market Report Key Takeaways from the Ambulatory Surgical Centers Market Report To read more about the latest highlights related to the ambulatory surgical centers market, get a snapshot of the key highlights entailed in theGlobal Ambulatory Surgical Centers Market Report Ambulatory Surgical Centers Overview Ambulatory Surgical Centers (ASCs) represent a pivotal evolution in healthcare delivery, providing specialized surgical...
PR Newswire
23/05/2024

D-dimer Testing Market to Reach $2.2 Billion Globally by 2032 at 5.1% CAGR…

Request Sample of the Report on D-dimer Testing Market Forecast 2032 - https://www.alliedmarketresearch.com/request-sample/A298270 Request Sample of the Report on D-dimer Testing Market Forecast 2032 - https://www.alliedmarketresearch.com/request-sample/A298270 Prime Determinants of Growth The increasing prevalence of thrombotic disorders, rising demand for point-of-care D-dimer testing, and the emergence of aptamers as an alternative to antibodies are the factors expected to...
PR Newswire
23/05/2024

Nyxoah Announces Pricing of Offering

REGULATED INFORMATION INSIDE INFORMATIONNyxoah Announces Pricing of OfferingMont-Saint-Guibert, Belgium – May 23, 2024, 3:50 pm CET / 9:50 am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), announced today the pricing of an underwritten public offering in the United States, which includes shares sold in a private...
Nasdaq GlobeNewswire
23/05/2024

Vistin Pharma ASA: Minutes from the annual general meeting 2024

Vistin Pharma ASA (OSE: VISTN), please find attached the minutes from the annual general meeting held today, on the 23 May 2024. All matters were resolved as proposed in the call for the annual general meeting, including the proposal to distribute a dividend of total NOK 1 per share, to be paid partly in June (NOK 0.5) and November (NOK 0.5).For the June dividend of NOK 0.5 per share, the shares will be traded excluding the right (ex-date) on the 5 thof June, with payment date on or...
Nasdaq GlobeNewswire
23/05/2024

Theriva™ Biologics Announces Fast Track Designation Granted by the U.S. FDA for…

/nab-paclitaxel) as a first line therapy for patients with pancreatic ductal adenocarcinoma (PDAC). Previously, the FDA granted orphan drug designation to VCN-01 for treatment of PDAC. “The FDA's decision to grant FTD to VCN-01 highlights the urgent need for new treatment options for PDAC, which accounts for the 4 thhighest cause of cancer-associated deaths in the US and Europe,” said Steven A. Shallcross, Chief Executive Officer of Theriva Biologics. “VIRAGE, our Phase 2b trial evaluating...
Nasdaq GlobeNewswire
23/05/2024

Taro Shareholders Approve Merger with Sun Pharma

Uday Baldota, Chief Executive Officer of Taro, said, "Throughout our fifteen-year relationship with Sun Pharma, Taro has benefited from their global scale and resources. This merger will further enable us to compete effectively in our products and markets." Uday Baldota, Chief Executive Officer of Taro, said, "Throughout our fifteen-year relationship with Sun Pharma, Taro has benefited from their global scale and resources. This merger will further enable us to compete effectively…
PR Newswire
23/05/2024

Indivior to Host Analyst Teach-in Event in New York City; Reconfirms Full Year…

Link to today's analyst teach-in event Link to today's analyst teach-in event Webinar Registration - Zoom About Indivior Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to treat substance use disorders (SUD) and serious mental illnesses. Our vision is that all patients around the world will have access to evidence-based treatment for the chronic conditions and co-occurring disorders of SUD. Indivior is dedicated to...
PR Newswire
23/05/2024

Amphista Therapeutics unveils new differentiated mechanism of action for BRD9…

PRESS RELEASE Amphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Protein Degradation in Focus Symposium First presentation of a novel mechanism of action for the degradation of BRD9 – completely differentiated from cereblon- or VHL-based PROTACsAmphista's bifunctional BRD9 degraders selectively induce BRD9 to DCAF16 proximity and serve as molecular glues, leading to strong and rapid degradation of BRD9Discovery further underscores...
Nasdaq GlobeNewswire
23/05/2024

Disclosure of voting rights at AGM in Vistin Pharma ASA

In relation to the Annual General Meeting in Vistin Pharma ASA (OSE: VISTN), on the 23th of May, the Company's Chair of the Board, Øyvin Brøymer, has received open proxies to represent a total of 5 576 864 shares in the Company at the AGM, corresponding to 12.58% of the total number of votes and shares in the Company. Together with the 12 575 000 shares held by Øyvin Brøymer through Intertrade Shipping AS, he will represent a total of 18 151 864 votes at the AGM, corresponding to a total of...
Nasdaq GlobeNewswire
23/05/2024

NTC Ophthalmics lberica: Young ophthalmologists square in Zahara Los Atunes

Pedro Zorita, General Manager of NTC in Spain, discloses the aim of the event: "We set up this work meeting to contribute to the professional career of the participants. NTC's vocation towards R&D and evidence-based medicine is embodied in our concrete and proactive approach, which always inspires us." Pedro Zorita, General Manager of NTC inSpain, discloses the aim of the event: "We set up this work meeting to contribute to the professional career of the participants. NTC's…
PR Newswire
23/05/2024

New report from Access to Medicine Foundation shows what pharma companies can do…

New report from the Access to Medicine Foundation tracks five such projects across the pipelines of GSK, F2G, Innoviva, Venatorx (gepotidacin , olorofim, zoliflodacin and cefepime-taniborbactam, respectively) and Pfizer's recently approved aztreonam-avibactam (Emblaveo®). Collectively, these projects could save at least 160,000 lives annually by providing much-needed medicines to treat drug-resistant gonorrhoea, urinary tract infections, intra-abdominal infections, respiratory infections, and…
PR Newswire
23/05/2024

Hypercholesterolemia Market is Predicted to Exhibit Remarkable Growth by 2034…

Key Takeaways from the Hypercholesterolemia Market Report Key Takeaways from the Hypercholesterolemia Market Report Discover which therapies are expected to grab the major hypercholesterolemia market share @Hypercholesterolemia Market Report Hypercholesterolemia Overview Hypercholesterolemia is marked by abnormally high cholesterol levels in the bloodstream. Cholesterol, a fatty substance, is both produced internally and sourced from certain foods like egg yolks, meat, and...
PR Newswire
23/05/2024
Altri  Comunicati